About
Advancing science through cross-disciplinary collaboration Mission Critical Path Institute is a catalyst in the development of new approaches to advance medical innovation and regulatory science. They achieve this by leading teams that share data, knowledge, and expertise, resulting in sound, consensus-based science. Who they Are Critical Path Institute (C-Path) is a nonprofit, public-private partnership with the Food and Drug Administration (FDA) created under the auspices of the FDA’s Critical Path Initiative program in 2005. C-Path’s aim is to accelerate the pace and reduce the costs of medical product development through the creation of new data standards, measurement standards, and methods standards that aid in the scientific evaluation of the efficacy and safety of new therapies. These pre-competitive standards and approaches have been termed “drug development tools” (DDTs) by the FDA, which established a process for official review and confirmation of their validity for a gi
Position in the VCSift Database
- • 3,884 investors in VCSift focus on the healthtech sector.
- • 51 investors are based in Tucson, Arizona, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- healthtech
- Location
- Tucson, US
Contact Information
Find more investors like Critical
Search Investors